| The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment AT Raben, VS Marshe, A Chintoh, I Gorbovskaya, DJ Müller, MK Hahn Frontiers in neuroscience 11, 741, 2018 | 118 | 2018 |
| The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain S Kanji, TM Fonseka, VS Marshe, V Sriretnakumar, MK Hahn, DJ Müller European archives of psychiatry and clinical neuroscience 268, 3-15, 2018 | 91 | 2018 |
| GWAS-based machine learning approach to predict duloxetine response in major depressive disorder M Maciukiewicz, VS Marshe, AC Hauschild, JA Foster, S Rotzinger, ... Journal of psychiatric research 99, 62-68, 2018 | 88 | 2018 |
| Identifying the common genetic basis of antidepressant response O Pain, K Hodgson, V Trubetskoy, S Ripke, VS Marshe, MJ Adams, ... Biological psychiatry global open science 2 (2), 115-126, 2022 | 85* | 2022 |
| Genetic similarities between compulsive overeating and addiction phenotypes: a case for “food addiction”? N Carlier, VS Marshe, J Cmorejova, C Davis, DJ Müller Current psychiatry reports 17, 1-11, 2015 | 80 | 2015 |
| Physicians' opinions following pharmacogenetic testing for psychotropic medication LM Walden, EJ Brandl, A Changasi, JE Sturgess, A Soibel, JFD Notario, ... Psychiatry Research 229 (3), 913-918, 2015 | 66 | 2015 |
| The effects of video games on cognition and brain structure: potential implications for neuropsychiatric disorders TA Shams, G Foussias, JA Zawadzki, VS Marshe, I Siddiqui, DJ Müller, ... Current psychiatry reports 17, 1-15, 2015 | 65 | 2015 |
| Norepinephrine transporter gene variants and remission from depression with venlafaxine treatment in older adults VS Marshe, M Maciukiewicz, S Rej, AK Tiwari, E Sibille, DM Blumberger, ... American Journal of Psychiatry 174 (5), 468-475, 2017 | 55 | 2017 |
| Older molecular brain age in severe mental illness CW Lin, LC Chang, T Ma, H Oh, B French, R Puralewski, F Mathews, ... Molecular psychiatry 26 (7), 3646-3656, 2021 | 36 | 2021 |
| C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review VS Marshe, S Pira, O Mantere, B Bosche, KJ Looper, N Herrmann, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 442-451, 2017 | 35 | 2017 |
| Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response VS Marshe, M Maciukiewicz, AC Hauschild, F Islam, L Qin, AK Tiwari, ... Translational psychiatry 11 (1), 127, 2021 | 31 | 2021 |
| Pharmacogenetic implications for antidepressant pharmacotherapy in late-life depression: a systematic review of the literature for response, pharmacokinetics and adverse drug … VS Marshe, F Islam, M Maciukiewicz, C Bousman, HA Eyre, H Lavretsky, ... The American Journal of Geriatric Psychiatry 28 (6), 609-629, 2020 | 28 | 2020 |
| Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: A review of the literature VS Marshe, I Gorbovskaya, S Kanji, M Kish, DJ Müller Journal of Neural Transmission 126, 65-85, 2019 | 25 | 2019 |
| Molecular mechanisms in lithium-associated renal disease: a systematic review S Rej, S Pira, V Marshe, A Do, D Elie, KJ Looper, N Herrmann, DJ Müller International urology and nephrology 48, 1843-1853, 2016 | 24 | 2016 |
| Genome-wide association studies of placebo and duloxetine response in major depressive disorder M Maciukiewicz, VS Marshe, AK Tiwari, TM Fonseka, N Freeman, ... The pharmacogenomics journal 18 (3), 406-412, 2018 | 23 | 2018 |
| Childhood abuse history in depression predicts better response to antidepressants with higher serotonin transporter affinity: a pilot investigation LC Quilty, V Marshe, DSS Lobo, KL Harkness, DJ Müller, RM Bagby Neuropsychobiology 74 (2), 78-83, 2017 | 23 | 2017 |
| Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder M Maciukiewicz, VS Marshe, AK Tiwari, TM Fonseka, N Freeman, ... Pharmacogenomics 16 (17), 1919-1929, 2015 | 22 | 2015 |
| Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study F Islam, VS Marshe, L Magarbeh, BN Frey, RV Milev, CN Soares, ... Translational psychiatry 12 (1), 366, 2022 | 20 | 2022 |
| Investigation of the gut microbiome in patients with schizophrenia and clozapine-induced weight gain: protocol and clinical characteristics of first patient cohorts I Gorbovskaya, S Kanji, JCW Liu, NE MacKenzie, SM Agarwal, VS Marshe, ... Neuropsychobiology 79 (1), 5-12, 2020 | 18 | 2020 |
| ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study L Magarbeh, C Hassel, M Choi, F Islam, VS Marshe, CC Zai, R Zuberi, ... Clinical Pharmacology & Therapeutics 114 (1), 88-117, 2023 | 10 | 2023 |
Daniel J Müller (Mueller)Professor, University of Toronto / Centre for Addiction and Mental HealthEmail verificata su camh.ca